Regular screening mammography reduces breast cancer mortality.(1-3) As a re
sult, since 1987, organized breast cancer screening programs have been esta
blished in many jurisdictions in Europe, Australia and in all Canadian prov
inces. The process of screening does not make a diagnosis of cancer but rat
her identifies women with abnormalities who require additional diagnostic e
valuation. It is recognized that reporting an abnormal screening result cau
ses stress and anxiety for women.(4-7) Delays in determining a definitive d
iagnosis may interfere with a woman's productivity and may influence her co
mpliance with re-screening.(7,8)
The responsibility for evaluation of an abnormal screening result rests wit
h the screening program in the United Kingdom (UK) and Australia.(9,10) Dia
gnosis is accomplished by referral to interdisciplinary assessment clinics
which often operate one or two days per week and are affiliated with one or
more screening centres.
In Canada, for historical reasons, except in certain areas,(11,12) women wi
th abnormalities identified during a visit to an organized breast cancer sc
reening program are referred back to their family physician who rakes prima
ry responsibility for organizing the diagnostic evaluation, including refer
ral for diagnostic imaging and if required, surgical consultation and biops
y. Concern has been expressed that such a system could be associated with i
nappropriate delays in the assessment of an abnormal creening mammogram(4.1
3-16) but, to date, there has been no published systematic evaluation of th
e timeliness of investigation after an abnormal screening mammogram in a Ca
nadian organized breast screening program. This report details the sequence
of steps and the magnitude of regional variation in the timeliness of asse
ssment for women with abnormal screening mammograms detected through the Sc
reening Mammography Program of British Columbia (SMPBC) in 1993-94.